Explore Oriola's Annual Report 2024

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Annual General Meeting 2025

Key resolutions from the AGM held on 2 April: A dividend of EUR 0.07 per share shall be paid for the financial year 2024. The AGM approved a shareholder's proposal to combine the company's A and B share classes after which the company will have only one single share class.

Q&A about the combination of share classes Stock Exchange Release with all resolutions More information on the AGM page

Annual Report 2024

Growth through strategy implementation. Find out more about Oriola's year 2024.

Go to Annual Report

Financial Statements Release 2024

Strategy implementation enhances financial performance

Download report Download presentation Wetch the webcast recording

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

02.04.2025 | Stock exchange releases

Decisions of the constitutive meeting of the Board of Directors and decisions related to the combination of share classes of Oriola Corporation

02.04.2025 | Stock exchange releases

Resolutions of the Annual General Meeting of Oriola Corporation – Combination of share classes and thereto related directed issuance of shares without payment approved

12.03.2025 | Stock exchange releases

Oriola’s Annual Report 2024 published

See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts